MustBio Selected for J&J JLABS Korea Program
Support to Include Networking, Business Development, Clinical Strategy, Funding, and Business Models

MustBio has been officially selected as a member of Johnson & Johnson Innovation’s JLABS Korea program in December 2024.

Operated by Johnson & Johnson Innovation, JLABS is an open global network that provides selected companies with comprehensive support across the healthcare spectrum. This includes development expertise, mentorship, partnerships, and connections with other ventures, aimed at enhancing the capabilities of JLABS member companies.

In addition to technical support, the program introduces domestic companies to the global investment market and fosters collaboration opportunities between international investors and local ventures.

As a member of JLABS, MustBio had the opportunity to showcase its platform and pipeline at the Biotech Showcase, part of the JPM Healthcare Conference in January 2025.